ALOE VERA ROLE IN WINNING SOLUTIONS' ATHLETE'S FOOT PRODUCT
This article was originally published in The Tan Sheet
Executive Summary
ALOE VERA ROLE IN WINNING SOLUTIONS' ATHLETE'S FOOT PRODUCT is the "most important issue to be resolved" before the company begins a low-dose tolnaftate clinical study, FDA told Winning Solutions in a May 20 letter. Responding to a citizen's petition submitted by the company in January to support the use of a lower concentration of tolnaftate for athlete's foot (tinea pedis) than the 1% allowed in the September 1993 OTC topical antifungals final monograph, the agency noted that Winning Solutions has to first determine whether the 60% aloe vera base of its product serves as an inactive vehicle or an adjuvant in the formulation.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning